Share Name Share Symbol Market Type Share ISIN Share Description
Collagen Sol LSE:COS London Ordinary Share GB00B94T6Y14 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 3.70p 3.60p 3.80p 3.70p 3.70p 3.70p 28,055 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 3.5 -2.6 -0.8 - 12.01

Collagen Sol Share Discussion Threads

Showing 626 to 647 of 650 messages
Chat Pages: 26  25  24  23  22  21  20  19  18  17  16  15  Older
DateSubjectAuthorDiscuss
24/8/2018
19:53
Share placing coming This company looks bust to me
opodio
24/8/2018
09:55
 Collagen Solutions Plc(the "Company" or the "Group") AGM StatementDelivering on our growth strategy Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, will hold its Annual General Meeting at 11am today at their offices at 3 Robroyston Oval, Nova Business Park, Glasgow, G33 1AP. At the meeting, Jamal Rushdy, CEO of Collagen Solutions will make the following statement: "We are on track to meet our key initiatives for the year, including achieving financial performance to bring us in line with market expectations. Our commercial execution plans are on track, including the recently announced signing of new distribution partners in China and new development agreements closed in the first quarter of this year that offset a previously announced specific risk with a Korean customer. ChondroMimetic® is on track for both CE Mark and first-in-man surgery in this financial year, following a successful audit by our notified body regulator this month. "We are currently in negotiations with multiple distributors in Europe, which we expect to conclude in parallel with the ChondroMimetic® CE Mark. We also recently completed the initial animal studies for our proprietary bone graft product that will support partner discussions at the upcoming North American Spine Society meeting in September. Operationally, our New Zealand restructuring initiative is delivering the expected synergies and benefits, as the assets related to collagen production and R&D have been relocated to the UK and USA respectively with operational setup and validation underway according to plan. The New Zealand team is now fully focused on the tissue business and has already identified several new customer opportunities. Finally, we will continue to deliver more visibility and metrics to our investors relating to the value and progress within our core business."  Enquiries:  Collagen Solutions Plc Jamal Rushdy, CEO 
moontheloon
24/8/2018
09:44
Hang your head in shame opodia.... couldn't have been more wrong... but you want trying to be right... Everything going the right way now share price and in the background for cos. I continue to hold with confidence. Good luck all dyor
moontheloon
01/8/2018
09:47
will be down later this week
opodio
01/8/2018
09:41
suddenly woken up today - Has this been tipped somewhere ?
pugugly
29/7/2018
07:16
Looks finished
opodio
12/7/2018
09:50
Collagen Solutions (COS) results presentation July 2018 by Jamal Rushdy (CEO) and Hilary Spence (CFO) Http://www.piworld.co.uk/2018/07/12/collagen-solutions-cos-results-presentation-july-2018/ Jamal Rushdy Summary – 00:33 Revenue/other income – 06:10 Core business sales highlights - 07:10 Business shape – 11:25 Moving up the value chain - 13:00 Our customers’ product cycle - 14:14 Core business operational highlights - 16:38 Proprietary products - 19:40 Priorities for FY2019 – 21:04 Hilary Spence Commercial KPIs - 24:55 Jamal Rushdy Conclusion – 27:28
tomps2
11/7/2018
11:55
This COS (AKA Crock of Sh#t) won't deliver and won't disappear until the management have milked every available ounce out of it. Where's the incentive for management to start getting their fingers out. Options at ridiculously low prices???? Don't worry guys if you miss these targets we can just issue you with more options at even lower values until the whole shooting caboodle disappearas up your backsides. Have written this one off and one to be marked down to experience
interstellar
10/7/2018
07:31
Results out and pretty awful. But impressed with clarity of purpose expressed by Chairman and CEO. They remain pretty well funded and in a potentially very exciting area of the market.
18bt
13/4/2018
11:01
Come on share price don't stop.
1toad
06/4/2018
12:09
Options granted today at 2.7p....you couldn't make it up if you tried. f
fillipe
04/4/2018
11:51
Frankly, I'm amazed that the share price hasn't sunk a great deal further. Currently showing best bid/ask of 2.6p v 2.8p, although I'd bet that by the end of the week it won't be that high. f
fillipe
04/4/2018
08:53
Another poor year- same miserable excuse. Continues to disappoint and someone needs to be held to account.
interstellar
04/4/2018
07:59
OH dear - Yet another delay - Good concept but looks like very poor execution.
pugugly
01/3/2018
09:38
VIDEO: Collagen Solutions (COS) investor presentation 26.2.18 CEO Jamal Rushdy and new CFO Hilary Spence present a business overview and an update of the ChondroMimetic® clinical study. Http://www.piworld.co.uk/2018/03/01/collagen-solutions-cos-investor-presentation-26th-february-2018/ Jamal Rushdy CEO introduction – 00:18 Regenerative medicine overview – 01:12 What Collagen Solutions does – 2:40 Core business model – 5:53 Revenue trend – 9:39 ChondroMimetic® introduction – 10:21 Knee cartilage disease progression – 12:28 Current treatments – 14:55 ChondroMimetic® clinical study – 17:35 Study highlights – 18:31 Study data introduction – 22:16 Study results – 23:51 Market opportunities – 28:03 Key competitive differentiators – 31:55 Conclusions & next steps – 33:30 Q&A – 35:25 Other uses of ChondroMimetic®? – 35:26 US Regulation? – 37:10 How long does the treatment last? – 39:47 Other geographical markets? – 41:28 Partnerships? – 42:34 Cashflow – 44:50 End – 46:42
tomps2
21/2/2018
15:44
timbo - Thanks for link - Interesting case histories and product verification but no real guide to how will be driven forward BUT amybe price sentative and so not able to reveal.
pugugly
21/2/2018
14:16
There's a new interview with Jamal Rushdy on Proactive, I cannot access right now, but will look at it later: http://www.proactiveinvestors.co.uk/companies/news/191961/collagen-solutions-soars-after-positive-outcome-to-epic-chondromimetic-implants-study-191961.html
timbo003
21/2/2018
10:47
Looks like the big seller is still with us depressing price - Any thought as to hwo many they still are looking to unload ?
pugugly
21/2/2018
08:50
News this morning proves there is a product and a market. Needs the CE mark approval. Not clear whether submission or approval targeted for H2.
18bt
13/2/2018
13:47
not much cash left BUST in 18 months or less
lucicavi
06/2/2018
13:27
It's looking a bit like the latter at long last.
thorne3
05/2/2018
11:39
No published news but share price perking up - Anyone know if new broker's note published or mentioned in the weekend press or Mr Market waking up to potential ??
pugugly
Chat Pages: 26  25  24  23  22  21  20  19  18  17  16  15  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180924 13:04:15